Investing

Absci : ABSI

ABSI

Stock Data

$9.26

$0.25 (2.81%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Absci Corp is a pioneering company in the field of generative AI for drug discovery, based in Vancouver, Washington. Founded in 2011, it focuses on uncovering new drug targets and developing biotherapeutic candidates. By leveraging artificial intelligence, Absci aims to accelerate the pace of drug development, making it a key player in the pharmaceutical industry's future.